Total Payments
$2,313
2024 Payments
$17.29
Companies
20
Transactions
33
Medicare Patients
2,799
Medicare Billing
$584,125
Payment Breakdown by Category
Consulting$1,736 (75.1%)
Food & Beverage$478.32 (20.7%)
Education$98.50 (4.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,736 | 1 | 75.1% |
| Food and Beverage | $478.32 | 29 | 20.7% |
| Education | $98.50 | 3 | 4.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $1,754 | 2 | $0 (2020) |
| Genentech USA, Inc. | $111.50 | 5 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $70.91 | 4 | $0 (2022) |
| PUMA BIOTECHNOLOGY, INC. | $45.95 | 2 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $36.10 | 2 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $35.08 | 2 | $0 (2020) |
| Medtronic, Inc. | $34.30 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $29.58 | 2 | $0 (2023) |
| Seagen Inc. | $26.22 | 1 | $0 (2022) |
| Ipsen Biopharmaceuticals, Inc | $18.86 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.29 | 1 | Medtronic, Inc. ($17.29) |
| 2023 | $36.30 | 2 | Ipsen Biopharmaceuticals, Inc ($18.86) |
| 2022 | $114.43 | 6 | Novartis Pharmaceuticals Corporation ($34.12) |
| 2021 | $69.83 | 4 | PUMA BIOTECHNOLOGY, INC. ($21.42) |
| 2020 | $1,872 | 9 | GENZYME CORPORATION ($1,754) |
| 2019 | $190.92 | 10 | Genentech USA, Inc. ($111.50) |
| 2018 | $12.29 | 1 | Seattle Genetics, Inc. ($12.29) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/13/2024 | Medtronic, Inc. | OSTEOCOOL RF ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 08/31/2023 | Ipsen Biopharmaceuticals, Inc | Tazverik (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Oncology | ||||||
| 08/29/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $17.44 | General |
| Category: Oncology | ||||||
| 12/13/2022 | Medtronic, Inc. | OSTEOCOOL RF ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 10/18/2022 | PUMA BIOTECHNOLOGY, INC. | NERLYNX (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: ONCOLOGY | ||||||
| 09/22/2022 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: ONCOLOGY | ||||||
| 09/15/2022 | Seagen Inc. | ADCETRIS (Biological) | Education | In-kind items and services | $26.22 | General |
| Category: Oncology | ||||||
| 08/30/2022 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $12.55 | General |
| 04/28/2022 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: ONCOLOGY | ||||||
| 10/19/2021 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: ONC | ||||||
| 10/06/2021 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), FEMARA, PIQRAY | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: ONCOLOGY | ||||||
| 06/03/2021 | GlaxoSmithKline, LLC. | BLENREP (Biological) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: ONCOLOGY | ||||||
| 05/14/2021 | PUMA BIOTECHNOLOGY, INC. | NERLYNX (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2020 | GENZYME CORPORATION | JEVTANA (Drug) | Consulting Fee | Cash or cash equivalent | $1,736.00 | General |
| Category: Oncology | ||||||
| 06/30/2020 | SANOFI-AVENTIS U.S. LLC | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Oncology | ||||||
| 04/22/2020 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Oncology | ||||||
| 03/31/2020 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONONE CDX | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: ONCOLOGY | ||||||
| 02/25/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $12.14 | General |
| Category: Oncology | ||||||
| 02/18/2020 | Verastem, Inc. | Copiktra (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Hematology and Oncology | ||||||
| 02/13/2020 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug), Nexavar, Vitrakvi | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: Oncology | ||||||
| 02/11/2020 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug), Nexavar, Vitrakvi | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: Oncology | ||||||
| 01/21/2020 | AstraZeneca Pharmaceuticals LP | FASLODEX (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Oncology | ||||||
| 11/26/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $16.66 | General |
| 11/19/2019 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Oncology | ||||||
| 10/02/2019 | Genentech USA, Inc. | TECENTRIQ (Biological) | Education | In-kind items and services | $59.99 | General |
| Category: BioOncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 609 | 1,453 | $500,806 | $129,051 |
| 2022 | 8 | 679 | 1,600 | $422,632 | $141,987 |
| 2021 | 9 | 691 | 1,724 | $462,405 | $163,537 |
| 2020 | 10 | 820 | 1,882 | $442,775 | $149,550 |
Total Patients
2,799
Total Services
6,659
Medicare Billing
$584,125
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 18 | 19 | $7,372 | $1,942 | 26.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 330 | 982 | $191,346 | $57,486 | 30.0% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2020 | 42 | 173 | $27,680 | $27,440 | 99.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 107 | 228 | $67,521 | $20,319 | 30.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 69 | 80 | $45,760 | $12,776 | 27.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 75 | 176 | $36,432 | $10,394 | 28.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 37 | 81 | $24,057 | $6,891 | 28.6% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 48 | 48 | $20,724 | $6,363 | 30.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 44 | 44 | $16,929 | $4,155 | 24.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 50 | 52 | $5,342 | $1,900 | 35.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 18 | 18 | $6,984 | $1,825 | 26.1% |
About Dr. Ryan Raddin, MD
Dr. Ryan Raddin, MD is a Hematology & Oncology healthcare provider based in Midlothian, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1659588911.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Raddin, MD has received a total of $2,313 in payments from pharmaceutical and medical device companies, with $17.29 received in 2024. These payments were reported across 33 transactions from 20 companies. The most common payment nature is "Consulting Fee" ($1,736).
As a Medicare-enrolled provider, Raddin has provided services to 2,799 Medicare beneficiaries, totaling 6,659 services with total Medicare billing of $584,125. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology
- Location Midlothian, VA
- Active Since 05/17/2007
- Last Updated 05/24/2012
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1659588911
Products in Payments
- JEVTANA (Drug) $1,754
- TECENTRIQ (Biological) $59.99
- NERLYNX (Drug) $45.95
- ADCETRIS (Biological) $38.51
- Stivarga (Drug) $36.10
- OSTEOCOOL RF ABLATION SYSTEM (Device) $34.30
- PIQRAY (Drug) $34.12
- OPDIVO (Biological) $29.58
- Perjeta (Biological) $22.79
- FASLODEX (Drug) $20.86
- Tazverik (Drug) $18.86
- MEKINIST (Drug) $18.79
- Alecensa (Biological) $18.72
- KISQALI (Drug) $18.00
- SARCLISA (Biological) $17.72
- BLENREP (Biological) $17.44
- FOUNDATIONONE (Device) $16.73
- Beleodaq (Drug) $16.01
- CALQUENCE (Drug) $14.22
- Copiktra (Drug) $13.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.